Cortical Function Changes During Swallowing in Patients With Dysphagia in Lateral Medullary Syndrome
Launched by THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY · Jan 5, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the brain changes when patients with Lateral Medullary Syndrome (LMS) swallow food or liquids. People with LMS often have difficulty swallowing, known as dysphagia. Researchers want to see how the brain's activity and connections differ during swallowing in LMS patients compared to healthy individuals. They will use a special technology called functional near-infrared spectroscopy (fNIRS) to observe and compare brain activity in both groups.
To participate in this study, you need to be between 18 and 80 years old, right-handed, and have had your first stroke confirmed as LMS by an MRI. You should also have dysphagia confirmed by a swallow study and be able to cooperate during the testing. However, if you have other serious neurological or physical conditions, or if you are unable to cooperate, you won’t be eligible. If you join the study, you can expect to undergo tests that will help researchers better understand swallowing difficulties in LMS and potentially improve future treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The first ischemic stroke was confirmed by head MRI as LMS;
- • 18-80 years old, right-handed;
- • Dysphagia was confirmed by video fluoroscopic swallow study(VFSS);
- • Conscious enough to cooperate with fNIRS testing;
- • No previous neurological or mental illness.
- Exclusion Criteria:
- • Other central nervous system diseases (Parkinson's disease, Alzheimer's disease, intracranial tumors, etc.);
- • Other diseases causing dysphagia (tumors of the esophagus, larynx, nasopharynx, etc.);
- • Serious physical diseases (cancer, fracture, etc.);
- • Other mental disorders (mania, schizophrenia, etc.);
- • Unconscious, unable to cooperate with the examination
About The First Affiliated Hospital Of Zhengzhou University
The First Affiliated Hospital of Zhengzhou University is a leading medical institution dedicated to advancing healthcare through innovative clinical research. As a prominent teaching hospital, it combines cutting-edge medical practices with a commitment to patient-centered care. The hospital is recognized for its comprehensive array of specialties and its collaborative approach to research, fostering partnerships with academic and healthcare organizations. By engaging in rigorous clinical trials, the hospital aims to contribute to the development of new therapies and improve treatment outcomes, ultimately enhancing the quality of care for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zhengzhou, Henan, China
Zhengzhou, Henan, China
Zhengzhou, Henan, China
Patients applied
Trial Officials
Yi Li
Study Chair
The First Affiliated Hospital of Zhengzhou University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported